Characterization of human osteoarthritic cartilage using optical and magnetic resonance imaging

Molecular Imaging and Biology

Volumn 14, Issue 1, 2012, Pages 32-39

  Jones, Ella F ^a   Schooler, Joseph ^a   Miller, David C ^a   Drake, Christopher R ^a   Wahnishe, Hilla ^a   Siddiqui, Sarmad ^a   Li, Xiaojuan ^a   Majumdar, Sharmila ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Matrix metalloproteinase; MR imaging; Optical imaging; Osteoarthritis; Proteoglycans

Indexed keywords

MATRIX METALLOPROTEINASE; PROTEOGLYCAN;

ARTICLE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMUR CONDYLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; TISSUE STRUCTURE; TOTAL KNEE REPLACEMENT; WHOLE BODY SCANNER;

ANALYSIS OF VARIANCE; CARTILAGE, ARTICULAR; HISTOCYTOCHEMISTRY; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS, KNEE; PROTEOGLYCANS;

EID: 84858725896     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0480-8     Document Type: Article

References (52)

1. AHRQ (2008) Big Money: Cost of 10 Most Expensive Health Conditions Near $500 Billion. AHRQ News and Numbers, January 23, 2008. http://www.ahrq.gov/news/nn/nn012308.htm. Accessed 13 Jan 2010
2. Srikulmontree T (2006) Osteoarthritis: The American College of Rheumatology. Downloaded from http://www.rheumatology.org/practice/clinical/ patients/diseases-and-conditions/osteoarthritis.asp. Accessed 13 Jan 2010
3. Link T, Stahl R, Woertler K (2007) Cartilage imaging: motivation, techniques, current and future significance. Eur Radiol 17:1135-1146 (Pubitemid 46691942)
4. Burstein D, Gray M, Mosher T, Dardzinski B (2009) Measures of molecular composition and structure in osteoarthritis. Radiol Clin North Am 47:675-686
5. Borthakur A, Mellon E, Niyogi S, Witschey W, Kneeland JB, Reddy R (2006) Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage. NMR Biomed 19:781-821 (Pubitemid 44811543)
6. Nieminen MT, Rieppo J, Toyras J et al (2001) T2 relaxation reveals spatial collagen architecture in articular cartilage: a comparative quantitative MRI and polarized light microscopic study. Magn Reson Med 46:487-493 (Pubitemid 32831323)
7. Watrin A, Ruaud JPB, Olivier PTA et al (2001) T2 mapping of rat patellar cartilage. Radiology 219:395-402 (Pubitemid 32336352)
8. Akella SV, Regatte RR, Gougoutas AJ et al (2001) Proteoglycan-induced changes in T1rho-relaxation of articular cartilage at 4 T. Magn Reson Med 46:419-423 (Pubitemid 32831313)
9. Duvvuri U, Kudchodkar S, Reddy R, Leigh JS (2002) T(1rho) relaxation can assess longitudinal proteoglycan loss from articular cartilage in vitro. Osteoarthritis Cartilage 10:838-844 (Pubitemid 35378768)
10. Wheaton AJ, Dodge GR, Elliott DM, Nicoll SB, Reddy R (2005) Quantification of cartilage biomechanical and biochemical properties via T1rho magnetic resonance imaging. Magn Reson Med 54:1087-1093 (Pubitemid 41567186)
11. Li X, Cheng J, Lin K et al (2010) Quantitative MRI using T(1rho) and T (2) in human osteoarthritic cartilage specimens: correlation with biochemical measurements and histology. Magn Reson Imaging (in press)
12. Mosher TJ, Dardzinski BJ, Smith MB (2000) Human articular cartilage: influence of aging and early symptomatic degeneration on the spatial variation of T2 - preliminary findings at 3 T. Radiology 214:259-266 (Pubitemid 30019902)
13. Dunn TC, Lu Y, Jin H, Ries MD, Majumdar S (2004) T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology 232:592-598 (Pubitemid 38971304)
14. Regatte RR, Akella SV, Borthakur A et al (2003) In vivo proton MR three-dimensional T1rho mapping of human articular cartilage: initial experience. Radiology 229:269-274 (Pubitemid 37152135)
15. Li X, Benjamin Ma C, Link TM et al (2007) In vivo T(1rho) and T(2) mapping of articular cartilage in osteoarthritis of the knee using 3 T MRI. Osteoarthritis Cartilage 15:789-797 (Pubitemid 46888159)
16. Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology 44:7-16 (Pubitemid 40136474)
17. Martel-Pelletier J, Welsch DJ, Pelletier JP (2001) Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 15:805-829 (Pubitemid 34092514)
18. Aigner T, Fundel K, Saas J et al (2006) Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 54:3533-3544 (Pubitemid 44737165)
19. Murphy G, Knauper V, Atkinson S et al (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39-S49
20. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516 (Pubitemid 33096184)
21. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578-5582
22. Dreier R, Grässel S, Fuchs S, Schaumburger J, Bruckner P (2004) Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell Res 297:303-312 (Pubitemid 38798395)
23. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316-333 (Pubitemid 32336342)
24. Kopka K, Breyholz HJ, Wagner S et al (2004) Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo. Nucl Med Biol 31:257-267 (Pubitemid 38315121)
25. Jaffer FA, Weissleder R (2004) Seeing within: molecular imaging of the cardiovascular system. Circ Res 94:433-445 (Pubitemid 38326278)
26. Mahmood U, Weissleder R (2003) Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2:489-496
27. Bremer C, Bredow S, Mahmood U, Weissleder R, Tung C-H (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221:523-529 (Pubitemid 33043440)
28. Seltzer JL, Akers KT, Weingarten H, Grant GA, McCourt DW, Eisen AZ (1990) Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides. J Biol Chem 265:20409-20413 (Pubitemid 120014024)
29. Peterson J, Kossodo S, Korideck H et al (2008) Optical imaging of MMPSense as a biomarker of matrix metalloprotease activity in vivo. In: Abstract no. 1130 of the 99th AACR Annual Meeting. San Diego, CA
30. Groves K, Kossodo S, Handy E et al (2009) Abstract #LB-68: In vivo imaging of treatment effects using a novel near infrared labeled agent. AACR Meeting Abstracts: LB-68, 2009
31. Gabriely G, Wurdinger T, Kesari S et al (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28:5369-5380
32. Littlepage LE, Sternlicht MD, Rougier N et al (2010) Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 70:2224-2234
33. Schaffer BS, Grayson MH, Wortham JM et al (2010) Immune competency of a hairless mouse strain for improved preclinical studies in genetically engineered mice. Mol Cancer Ther 9:2354-2364
34. Peterson J, LaBranche T, Vasquez K et al (2010) Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis. Arthritis Res Ther 12:R105
35. Li X, Han ET, Busse RF, Majumdar S (2008) In vivo T(1rho) mapping in cartilage using 3D magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots (3D MAPSS). Magn Reson Med 59:298-307 (Pubitemid 351220093)
36. Pai A, Li X, Majumdar S (2008) A comparative study at 3 T of sequence dependence of T2 quantitation in the knee. Magn Reson Imaging 26:1215-1220
37. Carballido-Gamio J, Krug R, Huber MB et al (2009) Geodesic topological analysis of trabecular bone microarchitecture from high-spatial resolution magnetic resonance images. Magn Reson Med 61:448-456
38. Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230-237
39. Kamekura S, Hoshi K, Shimoaka T et al (2005) Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13:632-641 (Pubitemid 40867863)
40. E.F. Jones, et al.: Human OA Cartilage Characterization with Optical and MR Imaging
41. David-Vaudey E, Ghosh S, Ries M, Majumdar S (2004) T2 relaxation time measurements in osteoarthritis. Magn Reson Imaging 22:673-682
42. Clements DN, Fitzpatrick N, Carter SD, Day PJ (2009) Cartilage gene expression correlates with radiographic severity of canine elbow osteoarthritis. Vet J 179:211-218
43. Kevorkian L, Young DA, Darrah C et al (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131-141 (Pubitemid 38084297)
44. Davidson RK, Waters JG, Kevorkian L et al (2006) Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8:R124
45. Graves EE, Ripoll J, Weissleder R, Ntziachristos V (2003) A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys 30:901-911 (Pubitemid 36578694)
46. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375-378 (Pubitemid 29166041)
47. Li X, Pai A, Blumenkrantz G et al (2009) Spatial distribution and relationship of T1rho and T2 relaxation times in knee cartilage with osteoarthritis. Magn Reson Med 61:1310-1318
48. Regatte RR, Akella SV, Lonner JH, Kneeland JB, Reddy R (2006) T1rho relaxation mapping in human osteoarthritis (OA) cartilage: comparison of T1rho with T2. J Magn Reson Imaging 23:547-553
49. Stahl R, Luke A, Li X et al (2009) T1rho, T2 and focal knee cartilage abnormalities in physically active and sedentary healthy subjects versus early OA patients-a 3.0-Tesla MRI study. Eur Radiol 19:132-143
50. Mosher TJ, Dardzinski BJ (2004) Cartilage MRI T2 relaxation time mapping: overview and applications. Semin Musculoskelet Radiol 8:355-368 (Pubitemid 40083118)
51. Brandt KD, Doherty M, Lohmander LS (eds) (1998) Osteoarthritis. Oxford University Press, Inc., New York
52. Watanabe HY, Yoshihiko, Kimata (1998) Koji Roles of Aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J Biochem 124:687